Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766893 · ClinicalTrials.gov registry record · Early Phase 1
Medication Maintenance Therapy in Community Pharmacy Settings
A Early Phase 1 study, sponsored by Lifespan.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03766893 is a Early Phase 1 study that has completed, run by Lifespan. The registered enrollment target is 11 participants.
The verdict
NCT03766893, a Early Phase 1 study, has completed, sponsored by Lifespan.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.
Interventions
- DRUG Buprenorphine / Naloxone Oral Product
- DRUG injectable naltrexone
- OTHER Pharmacy maintenance addiction care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2018-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03766893
The ClinicalTrials.gov registry entry for NCT03766893 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lifespan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine / Naloxone Oral Product is the first listed.
NCT03766893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03766893 about?
NCT03766893 is a clinical study titled "Medication Maintenance Therapy in Community Pharmacy Settings". The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.
What is the current status of trial NCT03766893?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2018-09-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03766893?
The interventions under investigation include: Buprenorphine / Naloxone Oral Product (DRUG), injectable naltrexone (DRUG), Pharmacy maintenance addiction care (OTHER).
Who is sponsoring clinical trial NCT03766893?
This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.